- Home
- AUPH vs PDX Comparison
AUPH vs PDX Comparison
Compare AUPH & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- PDX
- Stock Information
- Founded
- AUPH 1993
- PDX 2019
- Country
- AUPH Canada
- PDX NY
- Employees
- AUPH N/A
- PDX N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- PDX Finance/Investors Services
- Sector
- AUPH Health Care
- PDX Finance
- Exchange
- AUPH Nasdaq
- PDX Nasdaq
- Market Cap
- AUPH 999.8M
- PDX 1.1B
- IPO Year
- AUPH 1999
- PDX N/A
- Fundamental
- Price
- AUPH $7.85
- PDX $22.69
- Analyst Decision
- AUPH Strong Buy
- PDX
- Analyst Count
- AUPH 2
- PDX 0
- Target Price
- AUPH $11.50
- PDX N/A
- AVG Volume (30 Days)
- AUPH 1.1M
- PDX N/A
- Earning Date
- AUPH 05-12-2025
- PDX 01-01-0001
- Dividend Yield
- AUPH N/A
- PDX 4.95%
- EPS Growth
- AUPH N/A
- PDX N/A
- EPS
- AUPH 0.27
- PDX N/A
- Revenue
- AUPH $247,295,000.00
- PDX N/A
- Revenue This Year
- AUPH $11.86
- PDX N/A
- Revenue Next Year
- AUPH $24.96
- PDX N/A
- P/E Ratio
- AUPH $29.71
- PDX N/A
- Revenue Growth
- AUPH 29.20
- PDX N/A
- 52 Week Low
- AUPH $4.98
- PDX $13.52
- 52 Week High
- AUPH $10.67
- PDX $21.05
- Technical
- Relative Strength Index (RSI)
- AUPH 44.68
- PDX 56.96
- Support Level
- AUPH $7.89
- PDX $21.65
- Resistance Level
- AUPH $8.49
- PDX $23.00
- Average True Range (ATR)
- AUPH 0.30
- PDX 0.53
- MACD
- AUPH -0.02
- PDX 0.16
- Stochastic Oscillator
- AUPH 36.95
- PDX 81.21
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.